Streck, Inc. and Anopoli Biomedical Systems, an Austrian distributor of life sciences, molecular diagnostics and microarray products, have signed a distribution agreement for Streck’s cell stabilization and molecular products.
Streck’s cell stabilization products include Cell-Free DNA BCT® CE, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; and Cell-Free RNA BCT® CE, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage. The tubes are for Export Only. Not for sale in the U.S.
Streck’s Molecular Products division is focused on the generation of rapid diagnostic tools that impact healthcare decisions. Streck’s molecular product line includes the ARM-D® Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the soon-to-launch rapid real-time PCR instrument, the Zulu RT™, capable of 40 cycle reactions in 20 minutes or less. In addition, Streck is developing a library of diagnostics tools that will soon be available in Austria and the rest of the world.
About Anopoli Biomedical Systems
Established in 1997, Anopoli Biomedical Systems originally distributed instruments for prostate and bladder cancer diagnosis and monitoring. The company added real-time PCR reagents, probes and instruments to its portfolio in 2002, and microarray instruments and accessories in 2005. Today’s products include real-time PCR kits for leukemia translocation screening, next generation sequencing, epigenetics and microbiomics.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.